flecainide has been researched along with Kidney Diseases in 3 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flecainide disposition was altered in the PMs." | 1.28 | The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide. ( Beckmann, J; Eichelbaum, M; Gross, AS; Gundert-Remy, U; Hertrampf, R; Mikus, G, 1989) |
| " Plasma elimination half-life after the single dose (20." | 1.27 | Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function. ( Conard, GJ; Cutler, RE; Forland, SC; Kvam, DC; McQuinn, RL; Miller, AM; Parish, S, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikus, G | 1 |
| Gross, AS | 1 |
| Beckmann, J | 1 |
| Hertrampf, R | 1 |
| Gundert-Remy, U | 1 |
| Eichelbaum, M | 1 |
| Braun, J | 1 |
| Kollert, JR | 1 |
| Becker, JU | 1 |
| Forland, SC | 1 |
| Cutler, RE | 1 |
| McQuinn, RL | 1 |
| Kvam, DC | 1 |
| Miller, AM | 1 |
| Conard, GJ | 1 |
| Parish, S | 1 |
3 other studies available for flecainide and Kidney Diseases
| Article | Year |
|---|---|
The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide.
Topics: Adult; Analysis of Variance; Chromatography, High Pressure Liquid; Debrisoquin; Female; Flecainide; | 1989 |
Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function.
Topics: Female; Flecainide; Half-Life; Humans; Kidney Diseases; Kinetics; Male; Middle Aged | 1987 |
Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function.
Topics: Adult; Aged; Female; Flecainide; Half-Life; Humans; Kidney Diseases; Male; Middle Aged | 1988 |